Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer.

The Journal of surgical research - 1 Dec 2020

Caskey Rachel, Singletary Brandon, Ayre Kareen, Parker Catherine, Krontiras Helen, Lancaster Rachael B

Abstract excerpt

BACKGROUND: The University of Alabama at Birmingham Preventative Care Program for Women's Cancer provides genetic testing, risk evaluation, and screening for breast cancer. Women diagnosed with high-risk mutations may opt to undergo active surveillance or prophylactic surgery. This decision requires understanding of the surveillance process and its potential outcomes. In this study, we report specifically on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Breast
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Decision Making

Share to Early Detection of Cancer

Share to Mammography

Share to Prophylactic Mastectomy

Source

Identifiers

PMID: 32712440
DOI: 10.1016/j.jss.2020.06.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer.PMID 32712440Read ↗

Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations.Semantic proximity Read ↗

Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.Semantic proximity Read ↗

Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.Semantic proximity Read ↗

Screening for familial cancer risk: Focus on breast cancer.Semantic proximity Read ↗

Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population.Semantic proximity Read ↗

Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.Semantic proximity Read ↗

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.Semantic proximity Read ↗

Penetrance of breast cancer genes from the eMERGE III NetworkSemantic proximity Read ↗

Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers.Semantic proximity Read ↗

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.Semantic proximity Read ↗

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.